Cytek Biosciences (CTKB) Other Non-Current Assets (2020 - 2026)

Cytek Biosciences' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $6.3 million for Q1 2026.

• Quarterly Other Non-Current Assets changed N/A year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (changed N/A YoY) and the FY2025 annual result came in at $6.7 million, up 40.87% from the prior year.
• Other Non-Current Assets was $6.3 million for Q1 2026 at Cytek Biosciences, down from $6.7 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $6.7 million in Q4 2025 and bottomed at $331000.0 in Q4 2023.
• A 5-year average of $3.5 million and a median of $3.1 million in 2023 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets tumbled 88.81% — and 2024, when it surged 1337.76%.
• Cytek Biosciences' Other Non-Current Assets stood at $3.0 million in 2022, then tumbled by 88.81% to $331000.0 in 2023, then jumped by 1337.76% to $4.8 million in 2024, then surged by 40.87% to $6.7 million in 2025, then slipped by 5.94% to $6.3 million in 2026.
• Business Quant data shows CTKB's Other Non-Current Assets at $6.3 million in Q1 2026, $6.7 million in Q4 2025, and $4.8 million in Q4 2024.